-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
-
-
-
-
-
-
-
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Misses Q4 EPS by 6c
-
-
-
-
-
-
-
Arcus (RCUS) and Gilead (GILD) Report New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen
-
-
-
-
-
-
-
Arcus Biosciences (RCUS) Tops Q1 EPS by 6c
-
-
-
-
-
-
-
Gilead (GILD) and Arcus Biosciences (RCUS) Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer
-
1,197,266 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

